2023 House Bill 4913

Crimes: controlled substances; sale, distribution, or possession of xylazine; prohibit.

A bill to amend 1978 PA 368, entitled “Public health code,” by amending section 7214 (MCL 333.7214), as amended by 2018 PA 107.

Official record

House Fiscal Agency Analysis

House Bill 4913 would amend the Public Health Code to designate xylazine as a Schedule 2 controlled substance. As described below, xylazine is a nonopioid drug used by veterinarians as a tranquilizer and anesthetic for larger animals such as horses, cattle, and deer. Xylazine is increasingly being found in samples of illicit drugs and implicated in drug overdoses.

Introduced in the House

July 18, 2023

Introduced by Rep. Kelly Breen (D-21) and 24 co-sponsors

Co-sponsored by Reps. Veronica Paiz (D-11), Mike Harris (R-52), Mike Mueller (R-72), Brian BeGole (R-71), Kara Hope (D-74), Phil Skaggs (D-80), Samantha Steckloff (D-19), Mike McFall (D-8), Natalie Price (D-5), Carol Glanville (D-84), Tyrone Carter (D-1), Kevin Coleman (D-25), Betsy Coffia (D-103), Sharon MacDonell (D-56), Helena Scott (D-7), Christine Morse (D-40), Jasper Martus (D-69), Matt Koleszar (D-22), Penelope Tsernoglou (D-75), Jennifer Conlin (D-48), Jim Haadsma (D-44), Alabas Farhat (D-3), Denise Mentzer (D-61) and Jason Hoskins (D-18)

Referred to the Committee on Judiciary